Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07561541 · ClinicalTrials.gov registry record · Phase 4
Extended Oral Antibiotic Prophylaxis in Diabetic Fracture Patients
A Phase 4 study, sponsored by Texas Tech University Health Sciences Center, El Paso.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT07561541 is a Phase 4 study that is actively recruiting participants, run by Texas Tech University Health Sciences Center, El Paso. The registered enrollment target is 40 participants.
The verdict
NCT07561541, a Phase 4 study, is actively recruiting participants, sponsored by Texas Tech University Health Sciences Center, El Paso.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if taking an antibiotic pill for 7 days after surgery reduces the risk of wound infection in adults with poorly controlled diabetes who have surgery to fix a broken bone in the leg, ankle, or foot. It will also learn about the safety of the extended antibiotic course. The main questions it aims to answer are: Does a 7-day antibiotic course after surgery lower the rate of wound infection within 90 days? What medical problems do participants have when taking the extended antibiotic course? Researchers will compare a 7-day course of an oral antibiotic (cefadroxil) to standard care (no additional antibiotics after surgery) to see if the extended course reduces infections. Participants will: Take an antibiotic pill or receive standard care for 7 days after surgery Receive a phone call from the study team about 1 week after surgery Visit the clinic at 3 weeks, 6 weeks, and 3 months after surgery for checkups
Interventions
- DRUG Clindamycin
- DRUG Cefadroxil 500 mg Capsules
- DRUG Bactrim DS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-04-01 |
| Est. Completion | 2027-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07561541
The ClinicalTrials.gov registry entry for NCT07561541 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, El Paso, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Clindamycin is the first listed.
NCT07561541 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07561541 about?
NCT07561541 is a clinical study titled "Extended Oral Antibiotic Prophylaxis in Diabetic Fracture Patients". The goal of this clinical trial is to learn if taking an antibiotic pill for 7 days after surgery reduces the risk of wound infection in adults with poorly controlled diabetes who have surgery to fix a broken bone in the leg, ankle, or foot. It will also learn about the safety of the extended antibi...
What is the current status of trial NCT07561541?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2026-04-01. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT07561541?
The interventions under investigation include: Clindamycin (DRUG), Cefadroxil 500 mg Capsules (DRUG), Bactrim DS (DRUG).
Who is sponsoring clinical trial NCT07561541?
This trial is sponsored by Texas Tech University Health Sciences Center, El Paso, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.